CSC
IDXX icon

Cove Street Capital’s Idexx Laboratories IDXX Stock Holding History

Cove Street Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$115K Hold
180
– – 0.15% 60
2025
Q2 		$96.5K Hold
180
– – 0.14% 67
2025
Q1 		$75.6K Hold
180
– – 0.12% 71
2024
Q4 		$74.4K Hold
180
– – 0.09% 73
2024
Q3 		$90.9K Buy
+180
New +$87.4K 0.07% 74

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Cove Street Capital's IDXX Position: Q3 2025 in Review

Cove Street Capital held its Idexx Laboratories (IDXX) position steady in Q3 2025 at 180 shares worth $115K. The position accounts for 0.15% of the portfolio, ranked #60.

Cove Street Capital first reported a position in IDXX in Q3 2024 and has held it in 5 quarters since. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Cove Street Capital held 180 shares of Idexx Laboratories worth $115K as of Q3 2025.
  • Cove Street Capital left its Idexx Laboratories share count unchanged in Q3 2025.
  • Idexx Laboratories made up 0.15% of Cove Street Capital's portfolio in Q3 2025, its #60 holding.
  • Cove Street Capital first reported a position in Idexx Laboratories in Q3 2024 and has held it in 5 quarters since.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Cove Street Capital's 13F filing for Q3 2025, filed 13 Nov 2025.